We could see that anifrolumab was able to abolish the increased expression of these genes not only in IFN-stimulated organoids but more importantly also in combination with SLE serum stimulation making them indistinguishable to the control condition (Fig. 5B). Here, IFNA1 is linked to systemic lupus erythematosus.